Portfolio Holdings Detail for ISIN IE00BMBKBZ46

Stock Name / Fund	iShares S&P 500 Health Care Sector UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IUHE.AS(EUR) CXE
ETF Ticker	IUHE(EUR) Euronext Amsterdam

Holdings detail for VRTX

Show aggregate VRTX holdings

News associated with VRTX

ProShares Ultra QQQ Experiences Big Inflow

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra QQQ (Symbol: QLD) where we have detected an approximate $392.3 million dollar inflow -- that's a 7.2% increase week over week in outs - 2025-04-15 15:02:19

Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce

Yo-yos are fun for kids. But yo-yo stock markets aren't so fun for grown-up investors. And unfortunately, there's been a lot more down "yo" recently than up "yo." - 2025-04-15 08:45:00

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

"May you live in interesting times." - 2025-04-12 08:48:00

We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

Contrary to what you might read on social media, Warren Buffett isn't a fan of tariffs. Berkshire Hathaway even recently took the unusual step of issuing a press release refuting social media claims that Buffett applauded President Trump's economic policies. - 2025-04-10 07:52:00

Arrowstreet Capital Limited Partnership Takes $3.73 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Arrowstreet Capital Limited Partnership purchased a new stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,265 shares of the pharmaceutical company’s stock, valued at approximately $3,731,000. Several other […] - 2025-04-09 08:14:56

TQQQ, NFLX, GOOG, VRTX: Large Inflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares UltraPro QQQ (Symbol: TQQQ) where we have detected an approximate $480.8 million dollar inflow -- that's a 3.4% increase week over week in - 2025-04-07 15:35:24

Validea Detailed Fundamental Analysis - VRTX

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks - 2025-04-07 12:38:05

2 Stocks to Buy if You're Worried About a Recession

Is a recession coming? Our economic outlook seems increasingly gloomy due to President Trump's trade policies. Though things might not go that far, it's still worth planning ahead. - 2025-04-07 09:24:00

Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $567.00 Price Target at Bank of America

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective increased by Bank of America from $555.00 to $567.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the pharmaceutical company’s stock. Bank of America‘s price objective would indicate a potential upside of 16.97% from the company’s […] - 2025-04-02 06:00:47

Validea Detailed Fundamental Analysis - VRTX

Below is Validea's guru fundamental report for VERTEX PHARMACEUTICALS INC (VRTX). Of the 22 guru strategies we follow, VRTX rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks - 2025-03-28 14:31:33

Rattled by the Stock Market Sell-Off? These 3 Stocks Outperformed the S&P 500 During the Great Recession

The economy has been on shaky ground for a while, and President Trump's tariffs and trade wars could finally send it into a recession. That's a big concern for the market these days as consumers have been keeping discretionary spending to a minimum as high costs have created many - 2025-03-28 10:30:00

Notable ETF Outflow Detected - XLV, DHR, VRTX, SYK

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $702.0 million dollar outflow -- that's a 1.8% decrease - 2025-03-27 16:02:51

Brokerages Set Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) PT at $506.70

Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-six research firms that are covering the firm, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has given a strong […] - 2025-03-20 06:04:53

Notable ETF Outflow Detected - IVW, VRTX, FI, GEV

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $392.2 million dollar outflow -- that's a 0.8% decrease week over - 2025-03-19 15:41:35

3 Unstoppable Stocks You Can Buy Now Without Any Hesitation

Are you reluctant to invest in stocks right now? That's understandable. Fear, uncertainty, and doubt have become the norm in early 2025 with rising stock market volatility. - 2025-03-17 10:47:00

AlphaQuest LLC Sells 2,767 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

AlphaQuest LLC trimmed its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 84.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 517 shares of the pharmaceutical company’s stock after selling 2,767 shares during the period. AlphaQuest LLC’s holdings in Vertex Pharmaceuticals were worth $208,000 as […] - 2025-03-17 08:02:56

3 Stocks With Ironclad Balance Sheets for Long-Term Stability

Although sometimes overshadowed by the all-important income statement, the balance sheet can offer essential insights into a company's financial health. It revolves around the balance between a company’s assets and liabilities. It helps assess factors important to overall financ - 2025-03-13 11:22:00

Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Buy at StockNews.com

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday. A number of other equities analysts have also weighed in on VRTX. HC Wainwright reiterated a “buy” rating and issued a $550.00 price target on shares of […] - 2025-03-13 06:26:55

Rep. Jefferson Shreve Purchases Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Representative Jefferson Shreve (R-Indiana) recently bought shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). In a filing disclosed on March 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in Vertex Pharmaceuticals stock on February 24th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account. Representative Jefferson Shreve also recently made […] - 2025-03-12 06:04:59

IVW, AXP, FI, VRTX: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $306.8 million dollar outflow -- that's a 0.6% decrease week over - 2025-03-11 15:28:55

Company News for Mar 11, 2025

Companies in The News Are: VRTX, TSLA, NVDA, COIN - 2025-03-11 13:22:00

Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever

When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your seatbelt" when the air is turbulent. That could be good advice for investors right now, too. - 2025-03-11 09:31:00

Where Will Vertex Pharmaceuticals Be in 10 Years?

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since gained the regulatory nod for four more and become the global leader in the CF market - 2025-03-11 08:25:00

5 Top Stocks to Buy in March

2025 has gotten off to a choppy start as some of the most valuable U.S.-based companies are dragging down the major stock market indexes. But getting caught up in short-term market movements is a mistake. - 2025-03-04 11:15:00

XLV, SYK, DHR, VRTX: Large Outflows Detected at ETF

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $434.3 million dollar outflow -- that's a 1.1% decrease - 2025-02-21 16:22:43

Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to Hold Rating by StockNews.com

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. VRTX has been the subject of a number of other reports. Scotiabank raised their price objective on Vertex Pharmaceuticals from $433.00 to $450.00 and gave the stock […] - 2025-02-21 06:55:07

Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?

Vertex Pharmaceuticals has lagged behind the broader market over the past year, and Wall Street analysts are cautiously optimistic about the stock’s future. - 2025-02-20 14:51:41

Blue Trust Inc. Sells 2,077 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Blue Trust Inc. lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 76.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 634 shares of the pharmaceutical company’s stock after selling 2,077 shares during the period. Blue […] - 2025-02-19 09:02:04

IUSG, ANET, VRTX, PH: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P U.S. Growth ETF (Symbol: IUSG) where we have detected an approximate $324.0 million dollar outflow -- that's a 1.5% decrease we - 2025-02-13 15:47:21

Vertex Pharmaceuticals (NASDAQ:VRTX) Given “Hold” Rating at Needham & Company LLC

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. Other equities analysts have also issued reports about the stock. Citigroup started coverage on shares of Vertex Pharmaceuticals in a research report on Thursday, November 14th. […] - 2025-02-13 09:32:55

iShares S&P 500 Health Care Sector UCITS ETF VRTX holdings

Date	Number of VRTX Shares Held	Base Market Value of VRTX Shares	Local Market Value of VRTX Shares	Change in VRTX Shares Held	Change in VRTX Base Value	Current Price per VRTX Share Held	Previous Price per VRTX Share Held
2025-04-17 (Thursday)	121,133	USD 59,246,150	USD 59,246,150	0	USD 388,837	USD 489.1	USD 485.89
2025-04-16 (Wednesday)	121,133	USD 58,857,313	USD 58,857,313	0	USD -1,768,542	USD 485.89	USD 500.49
2025-04-15 (Tuesday)	121,133	USD 60,625,855	USD 60,625,855	-139	USD 495,559	USD 500.49	USD 495.83
2025-04-14 (Monday)	121,272	USD 60,130,296	USD 60,130,296	0	USD 1,407,968	USD 495.83	USD 484.22
2025-04-11 (Friday)	121,272	USD 58,722,328	USD 58,722,328	0	USD 1,058,705	USD 484.22	USD 475.49
2025-04-10 (Thursday)	121,272	USD 57,663,623	USD 57,663,623	-278	USD -959,942	USD 475.49	USD 482.3
2025-04-09 (Wednesday)	121,550	USD 58,623,565	USD 58,623,565	0	USD 1,206,991	USD 482.3	USD 472.37
2025-04-08 (Tuesday)	121,550	USD 57,416,574	USD 57,416,574	-139	USD -332,158	USD 472.37	USD 474.56
2025-04-07 (Monday)	121,689	USD 57,748,732	USD 57,748,732	-139	USD -73,273	USD 474.56	USD 474.62
2025-04-04 (Friday)	121,828	USD 57,822,005	USD 57,822,005	-278	USD -1,215,025	USD 474.62	USD 483.49
2025-04-02 (Wednesday)	122,106	USD 59,037,030	USD 59,037,030	139	USD -85,254	USD 483.49	USD 484.74
2025-04-01 (Tuesday)	121,967	USD 59,122,284	USD 59,122,284	1,251	USD 596,753	USD 484.74	USD 484.82
2025-03-31 (Monday)	120,716	USD 58,525,531	USD 58,525,531	-834	USD -1,360,939	USD 484.82	USD 492.69
2025-03-28 (Friday)	121,550	USD 59,886,470	USD 59,886,470	139	USD -1,128,628	USD 492.69	USD 502.55
2025-03-27 (Thursday)	121,411	USD 61,015,098	USD 61,015,098	0	USD 275,603	USD 502.55	USD 500.28
2025-03-26 (Wednesday)	121,411	USD 60,739,495	USD 60,739,495	-88	USD -1,108,356	USD 500.28	USD 509.04
2025-03-25 (Tuesday)	121,499	USD 61,847,851	USD 61,847,851	0	USD -328,047	USD 509.04	USD 511.74
2025-03-24 (Monday)	121,499	USD 62,175,898	USD 62,175,898	0	USD 1,037,601	USD 511.74	USD 503.2
2025-03-21 (Friday)	121,499	USD 61,138,297	USD 61,138,297	973	USD -351,658	USD 503.2	USD 510.18
2025-03-20 (Thursday)	120,526	USD 61,489,955	USD 61,489,955	556	USD 2,931	USD 510.18	USD 512.52
2025-03-19 (Wednesday)	119,970	USD 61,487,024	USD 61,487,024	0	USD 34,791	USD 512.52	USD 512.23
2025-03-18 (Tuesday)	119,970	USD 61,452,233	USD 61,452,233	0	USD -183,554	USD 512.23	USD 513.76
2025-03-17 (Monday)	119,970	USD 61,635,787	USD 61,635,787	-139	USD 1,008,367	USD 513.76	USD 504.77
2025-03-14 (Friday)	120,109	USD 60,627,420	USD 60,627,420	0	USD 222,202	USD 504.77	USD 502.92
2025-03-13 (Thursday)	120,109	USD 60,405,218	USD 60,405,218	0	USD 900,817	USD 502.92	USD 495.42
2025-03-12 (Wednesday)	120,109	USD 59,504,401	USD 59,504,401	-58	USD 822,048	USD 495.42	USD 488.34
2025-03-11 (Tuesday)	120,167	USD 58,682,353	USD 58,682,353	0	USD -1,402,349	USD 488.34	USD 500.01
2025-03-10 (Monday)	120,167	USD 60,084,702	USD 60,084,702	0	USD 1,408,358	USD 500.01	USD 488.29
2025-03-07 (Friday)	120,167	USD 58,676,344	USD 58,676,344	139	USD -334,222	USD 488.29	USD 491.64
2025-03-05 (Wednesday)	120,028	USD 59,010,566	USD 59,010,566	0	USD 650,552	USD 491.64	USD 486.22
2025-03-04 (Tuesday)	120,028	USD 58,360,014	USD 58,360,014	0	USD 349,281	USD 486.22	USD 483.31
2025-03-03 (Monday)	120,028	USD 58,010,733	USD 58,010,733	0	USD 422,499	USD 483.31	USD 479.79
2025-02-28 (Friday)	120,028	USD 57,588,234	USD 57,588,234	-417	USD 437,081	USD 479.79	USD 474.5
2025-02-27 (Thursday)	120,445	USD 57,151,153	USD 57,151,153	0	USD -554,047	USD 474.5	USD 479.1
2025-02-26 (Wednesday)	120,445	USD 57,705,200	USD 57,705,200	0	USD -150,556	USD 479.1	USD 480.35
2025-02-25 (Tuesday)	120,445	USD 57,855,756	USD 57,855,756	1,390	USD 512,915	USD 480.35	USD 481.65
2025-02-24 (Monday)	119,055	USD 57,342,841	USD 57,342,841	0	USD -308,352	USD 481.65	USD 484.24
2025-02-21 (Friday)	119,055	USD 57,651,193	USD 57,651,193	0	USD 465,505	USD 484.24	USD 480.33
2025-02-20 (Thursday)	119,055	USD 57,185,688	USD 57,185,688	973	USD 1,479,324	USD 480.33	USD 471.76
2025-02-19 (Wednesday)	118,082	USD 55,706,364	USD 55,706,364	417	USD 1,332,191	USD 471.76	USD 462.11
2025-02-18 (Tuesday)	117,665	USD 54,374,173	USD 54,374,173	278	USD 493,540	USD 462.11	USD 459
2025-02-17 (Monday)	117,387	USD 53,880,633	USD 53,880,633	0	USD 0	USD 459	USD 459
2025-02-14 (Friday)	117,387	USD 53,880,633	USD 53,880,633	0	USD -420,245	USD 459	USD 462.58
2025-02-13 (Thursday)	117,387	USD 54,300,878	USD 54,300,878	695	USD 1,416,064	USD 462.58	USD 453.2
2025-02-12 (Wednesday)	116,692	USD 52,884,814	USD 52,884,814	0	USD -235,718	USD 453.2	USD 455.22
2025-02-11 (Tuesday)	116,692	USD 53,120,532	USD 53,120,532	0	USD -1,721,207	USD 455.22	USD 469.97
2025-02-10 (Monday)	116,692	USD 54,841,739	USD 54,841,739	0	USD 75,850	USD 469.97	USD 469.32
2025-02-07 (Friday)	116,692	USD 54,765,889	USD 54,765,889	0	USD -1,381,634	USD 469.32	USD 481.16
2025-02-06 (Thursday)	116,692	USD 56,147,523	USD 56,147,523	0	USD -849,517	USD 481.16	USD 488.44
2025-02-05 (Wednesday)	116,692	USD 56,997,040	USD 56,997,040	0	USD 718,822	USD 488.44	USD 482.28
2025-02-04 (Tuesday)	116,692	USD 56,278,218	USD 56,278,218	556	USD 1,651,328	USD 482.28	USD 470.37
2025-02-03 (Monday)	116,136	USD 54,626,890	USD 54,626,890	0	USD 1,009,222	USD 470.37	USD 461.68
2025-01-31 (Friday)	116,136	USD 53,617,668	USD 53,617,668	139	USD 2,764,583	USD 461.68	USD 438.4
2025-01-30 (Thursday)	115,997	USD 50,853,085	USD 50,853,085	0	USD -361,910	USD 438.4	USD 441.52
2025-01-29 (Wednesday)	115,997	USD 51,214,995	USD 51,214,995	139	USD 158,692	USD 441.52	USD 440.68
2025-01-28 (Tuesday)	115,858	USD 51,056,303	USD 51,056,303	0	USD -370,746	USD 440.68	USD 443.88
2025-01-27 (Monday)	115,858	USD 51,427,049	USD 51,427,049	278	USD 615,769	USD 443.88	USD 439.62
2025-01-24 (Friday)	115,580	USD 50,811,280	USD 50,811,280	139	USD 48,409	USD 439.62	USD 439.73
2025-01-23 (Thursday)	115,441	USD 50,762,871	USD 50,762,871	0	USD 1,354,123	USD 439.73	USD 428
2025-01-22 (Wednesday)	115,441	USD 49,408,748	USD 49,408,748
2025-01-21 (Tuesday)	114,885	USD 49,158,143	USD 49,158,143
2025-01-20 (Monday)	114,885	USD 48,481,470	USD 48,481,470
2025-01-17 (Friday)	114,885	USD 48,481,470	USD 48,481,470
2025-01-16 (Thursday)	114,885	USD 47,902,450	USD 47,902,450
2025-01-15 (Wednesday)	114,885	USD 48,741,110	USD 48,741,110
2025-01-14 (Tuesday)	114,885	USD 47,293,559	USD 47,293,559
2025-01-13 (Monday)	114,885	USD 47,490,012	USD 47,490,012
2025-01-10 (Friday)	114,885	USD 47,052,301	USD 47,052,301
2025-01-09 (Thursday)	114,885	USD 47,345,257	USD 47,345,257
2025-01-09 (Thursday)	114,885	USD 47,345,257	USD 47,345,257
2025-01-09 (Thursday)	114,885	USD 47,345,257	USD 47,345,257
2025-01-08 (Wednesday)	114,885	USD 47,345,257	USD 47,345,257
2025-01-08 (Wednesday)	114,885	USD 47,345,257	USD 47,345,257
2025-01-08 (Wednesday)	114,885	USD 47,345,257	USD 47,345,257
2025-01-02 (Thursday)	114,746	USD 46,559,337	USD 46,559,337	-5,004	USD -9,629,758	USD 405.76	USD 469.22
2024-12-30 (Monday)	114,746	USD 45,823,815	USD 45,823,815
2024-12-10 (Tuesday)	119,750	USD 56,189,095	USD 56,189,095	-139	USD -635,893	USD 469.22	USD 473.98
2024-12-09 (Monday)	119,889	USD 56,824,988	USD 56,824,988	-3,614	USD -245,748	USD 473.98	USD 462.1
2024-12-06 (Friday)	123,503	USD 57,070,736	USD 57,070,736	0	USD 269,236	USD 462.1	USD 459.92
2024-12-05 (Thursday)	123,503	USD 56,801,500	USD 56,801,500	0	USD -501,422	USD 459.92	USD 463.98
2024-12-04 (Wednesday)	123,503	USD 57,302,922	USD 57,302,922	0	USD 865,756	USD 463.98	USD 456.97
2024-12-03 (Tuesday)	123,503	USD 56,437,166	USD 56,437,166	-1,668	USD -1,858,724	USD 456.97	USD 465.73
2024-12-02 (Monday)	125,171	USD 58,295,890	USD 58,295,890	-695	USD -625,761	USD 465.73	USD 468.13
2024-11-29 (Friday)	125,866	USD 58,921,651	USD 58,921,651	-138	USD 385,233	USD 468.13	USD 464.56
2024-11-28 (Thursday)	126,004	USD 58,536,418	USD 58,536,418	0	USD 0	USD 464.56	USD 464.56
2024-11-27 (Wednesday)	126,004	USD 58,536,418	USD 58,536,418	0	USD -316,270	USD 464.56	USD 467.07
2024-11-26 (Tuesday)	126,004	USD 58,852,688	USD 58,852,688	0	USD 675,381	USD 467.07	USD 461.71
2024-11-25 (Monday)	126,004	USD 58,177,307	USD 58,177,307	0	USD 1,353,283	USD 461.71	USD 450.97
2024-11-22 (Friday)	126,004	USD 56,824,024	USD 56,824,024	-1,380	USD -545,908	USD 450.97	USD 450.37
2024-11-21 (Thursday)	127,384	USD 57,369,932	USD 57,369,932	-690	USD -420,899	USD 450.37	USD 451.23
2024-11-20 (Wednesday)	128,074	USD 57,790,831	USD 57,790,831	1,104	USD 907,001	USD 451.23	USD 448.01
2024-11-19 (Tuesday)	126,970	USD 56,883,830	USD 56,883,830	0	USD -2,412,430	USD 448.01	USD 467.01
2024-11-18 (Monday)	126,970	USD 59,296,260	USD 59,296,260	-1,656	USD -3,730,480	USD 467.01	USD 490
2024-11-12 (Tuesday)	128,626	USD 63,026,740	USD 63,026,740	0	USD -1,507,497	USD 490	USD 501.72
2024-11-11 (Monday)	128,626	USD 64,534,237	USD 64,534,237	1,242	USD -1,290,171	USD 501.72	USD 516.74
2024-11-08 (Friday)	127,384	USD 65,824,408	USD 65,824,408	-4,416	USD -398,502	USD 516.74	USD 502.45
2024-11-07 (Thursday)	131,800	USD 66,222,910	USD 66,222,910	-276	USD 1,024,913	USD 502.45	USD 493.64
2024-11-06 (Wednesday)	132,076	USD 65,197,997	USD 65,197,997	0	USD -824,154	USD 493.64	USD 499.88
2024-11-05 (Tuesday)	132,076	USD 66,022,151	USD 66,022,151	0	USD 3,576,618	USD 499.88	USD 472.8
2024-11-04 (Monday)	132,076	USD 62,445,533	USD 62,445,533	0	USD 221,888	USD 472.8	USD 471.12
2024-11-01 (Friday)	132,076	USD 62,223,645	USD 62,223,645	-276	USD -773,260	USD 471.12	USD 475.98
2024-10-31 (Thursday)	132,352	USD 62,996,905	USD 62,996,905	-552	USD -143,127	USD 475.98	USD 475.08
2024-10-30 (Wednesday)	132,904	USD 63,140,032	USD 63,140,032	138	USD 692,216	USD 475.08	USD 470.36
2024-10-29 (Tuesday)	132,766	USD 62,447,816	USD 62,447,816	828	USD -403,489	USD 470.36	USD 476.37
2024-10-28 (Monday)	131,938	USD 62,851,305	USD 62,851,305	-414	USD -373,245	USD 476.37	USD 477.7
2024-10-25 (Friday)	132,352	USD 63,224,550	USD 63,224,550	0	USD 766,318	USD 477.7	USD 471.91
2024-10-24 (Thursday)	132,352	USD 62,458,232	USD 62,458,232	0	USD 246,174	USD 471.91	USD 470.05
2024-10-23 (Wednesday)	132,352	USD 62,212,058	USD 62,212,058	0	USD -643,230	USD 470.05	USD 474.91
2024-10-22 (Tuesday)	132,352	USD 62,855,288	USD 62,855,288	0	USD -420,880	USD 474.91	USD 478.09
2024-10-21 (Monday)	132,352	USD 63,276,168	USD 63,276,168	0	USD -649,848	USD 478.09	USD 483
2024-10-18 (Friday)	132,352	USD 63,926,016	USD 63,926,016

Share Trades of VRTX by Blackrock for IE00BMBKBZ46

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-04-15	SELL	-139			500.490*		476.28 Profit of 66,203 on sale
2025-04-10	SELL	-278			475.490*		475.98 Profit of 132,322 on sale
2025-04-08	SELL	-139			472.370*		475.95 Profit of 66,156 on sale
2025-04-07	SELL	-139			474.560*		475.96 Profit of 66,159 on sale
2025-04-04	SELL	-278			474.620*		475.98 Profit of 132,322 on sale
2025-04-02	BUY	139			483.490*		475.89
2025-04-01	BUY	1,251			484.740*		475.78
2025-03-31	SELL	-834			484.820*		475.67 Profit of 396,707 on sale
2025-03-28	BUY	139			492.690*		475.45
2025-03-26	SELL	-88			500.280*		474.79 Profit of 41,781 on sale
2025-03-21	BUY	973			503.200*		473.46
2025-03-20	BUY	556			510.180*		472.96
2025-03-17	SELL	-139			513.760*		471.28 Profit of 65,508 on sale
2025-03-12	SELL	-58			495.420*		469.97 Profit of 27,258 on sale
2025-03-07	BUY	139			488.290*		468.94
2025-02-28	SELL	-417			479.790*		467.87 Profit of 195,102 on sale
2025-02-25	BUY	1,390			480.350*		467.35
2025-02-20	BUY	973			480.330*		466.55
2025-02-19	BUY	417			471.760*		466.45
2025-02-18	BUY	278			462.110*		466.53
2025-02-13	BUY	695			462.580*		466.91
2025-02-04	BUY	556			482.280*		466.19
2025-01-31	BUY	139			461.680*		466.19
2025-01-29	BUY	139			441.520*		467.54
2025-01-27	BUY	278			443.880*		468.90
2025-01-24	BUY	139			439.620*		469.72
2025-01-02	SELL	-5,004			405.760*		472.48 Profit of 2,364,290 on sale
2024-12-10	SELL	-139			469.220*		472.58 Profit of 65,688 on sale
2024-12-09	SELL	-3,614			473.980*		472.54 Profit of 1,707,741 on sale
2024-12-03	SELL	-1,668			456.970*		474.22 Profit of 790,998 on sale
2024-12-02	SELL	-695			465.730*		474.53 Profit of 329,801 on sale
2024-11-29	SELL	-138			468.130*		474.78 Profit of 65,520 on sale
2024-11-22	SELL	-1,380			450.970*		477.88 Profit of 659,470 on sale
2024-11-21	SELL	-690			450.370*		479.25 Profit of 330,684 on sale
2024-11-20	BUY	1,104			451.230*		480.73
2024-11-18	SELL	-1,656			467.010*		483.46 Profit of 800,608 on sale
2024-11-11	BUY	1,242			501.720*		481.81
2024-11-08	SELL	-4,416			516.740*		479.31 Profit of 2,116,633 on sale
2024-11-07	SELL	-276			502.450*		477.53 Profit of 131,798 on sale
2024-11-01	SELL	-276			471.120*		474.49 Profit of 130,960 on sale
2024-10-31	SELL	-552			475.980*		474.31 Profit of 261,818 on sale
2024-10-30	BUY	138			475.080*		474.20
2024-10-29	BUY	828			470.360*		474.84
2024-10-28	SELL	-414			476.370*		474.53 Profit of 196,456 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer